BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 18297528)

  • 21. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognosis and chromosomal abnormalities in 79 children with t (8;21) acute myeloid leukemia].
    Chen YM; Liu TF; Ruan M; Zou Y; Chen XJ; Guo Y; Wang SC; Zhu XF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):542-6. PubMed ID: 19968066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of chromosome karyotype between myelodysplastic syndrome and acute leukemia patients confirmed at the same period].
    Jiang M; Wen BZ; Li L; Chen S; Cheng H; Hao JP; Chen R; Wang L; Zhao F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):387-92. PubMed ID: 24763010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia.
    Seifert H; Mohr B; Thiede C; Oelschlägel U; Schäkel U; Illmer T; Soucek S; Ehninger G; Schaich M;
    Leukemia; 2009 Apr; 23(4):656-63. PubMed ID: 19151774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
    Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
    Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of Chromosomal Abnormalities Commonly Observed in Adult Acute Myeloid Leukemia in Pakistan as Predictors of Prognosis.
    Shaikh MS; Ahmed ZA; Shaikh MU; Adil SN; Khurshid M; Moatter T; Rashid A; Karim F; Raheem A; Ali N
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1903-1906. PubMed ID: 30049204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Karyotype complexity and prognosis in acute myeloid leukemia.
    Stölzel F; Mohr B; Kramer M; Oelschlägel U; Bochtler T; Berdel WE; Kaufmann M; Baldus CD; Schäfer-Eckart K; Stuhlmann R; Einsele H; Krause SW; Serve H; Hänel M; Herbst R; Neubauer A; Sohlbach K; Mayer J; Middeke JM; Platzbecker U; Schaich M; Krämer A; Röllig C; Schetelig J; Bornhäuser M; Ehninger G
    Blood Cancer J; 2016 Jan; 6(1):e386. PubMed ID: 26771812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features of complex karyotype in newly diagnosed acute myeloid leukemia.
    Yoshida S; Onozawa M; Miyashita N; Kimura H; Takahashi S; Yokoyama S; Matsukawa T; Hirabayashi S; Mori A; Hidaka D; Minauchi K; Shigematsu A; Hashiguchi J; Igarashi T; Kakinoki Y; Tsutsumi Y; Ibata M; Kobayashi H; Haseyama Y; Fujimoto K; Ishihara T; Sakai H; Ota S; Kondo T; Teshima T
    Int J Hematol; 2023 Apr; 117(4):544-552. PubMed ID: 36572814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.
    Klein K; Kaspers G; Harrison CJ; Beverloo HB; Reedijk A; Bongers M; Cloos J; Pession A; Reinhardt D; Zimmerman M; Creutzig U; Dworzak M; Alonzo T; Johnston D; Hirsch B; Zapotocky M; De Moerloose B; Fynn A; Lee V; Taga T; Tawa A; Auvrignon A; Zeller B; Forestier E; Salgado C; Balwierz W; Popa A; Rubnitz J; Raimondi S; Gibson B
    J Clin Oncol; 2015 Dec; 33(36):4247-58. PubMed ID: 26573082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of
    Abbas HA; Ayoub E; Sun H; Kanagal-Shamanna R; Short NJ; Issa G; Yilmaz M; Pierce S; Rivera D; Cham B; Wing S; Li Z; Hammond D; Jabbour E; Borthakur G; Garcia-Manero G; Andreeff M; Daver N; Kadia T; Konopleva M; DiNardo C; Ravandi F
    Leuk Lymphoma; 2022 Dec; 63(13):3105-3116. PubMed ID: 36089905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype.
    Breems DA; Van Putten WL; De Greef GE; Van Zelderen-Bhola SL; Gerssen-Schoorl KB; Mellink CH; Nieuwint A; Jotterand M; Hagemeijer A; Beverloo HB; Löwenberg B
    J Clin Oncol; 2008 Oct; 26(29):4791-7. PubMed ID: 18695255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
    Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of fluorescence in situ hybridization for the detection of genomic aberrations in older patients with acute myeloid leukemia.
    Fröhling S; Kayser S; Mayer C; Miller S; Wieland C; Skelin S; Schlenk RF; Döhner H; Döhner K;
    Haematologica; 2005 Feb; 90(2):194-9. PubMed ID: 15710571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The cytogenetic characteristics of 178 acute myeloid leukemia patients].
    Liu H; Chang NB; Pei L; Ning SY; Li JT; Xing BL; Xu XD
    Zhonghua Nei Ke Za Zhi; 2011 Aug; 50(8):683-6. PubMed ID: 22093563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT.
    Poiré X; Labopin M; Polge E; Forcade E; Ganser A; Volin L; Michallet M; Blaise D; Yakoub-Agha I; Maertens J; Espiga CR; Cornelissen J; Finke J; Mohty M; Esteve J; Nagler A
    Haematologica; 2020; 105(2):414-423. PubMed ID: 31048355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletions of chromosome arms 7p and 7q in adult acute myeloid leukemia: a marker chromosome confirmed by array comparative genomic hybridization.
    Woo KS; Kim KE; Kim KH; Kim SH; Park JI; Shaffer LG; Han JY
    Cancer Genet Cytogenet; 2009 Oct; 194(2):71-4. PubMed ID: 19781438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific chromosomal aberrations in de novo acute myeloid leukemia: a comparative analysis of results with a report of three novel chromosomal rearrangements t(7;14)(q35;q13), t(8;18)(p11.2;q12), t(13;15) in Indian population.
    Ahmad F; Dalvi R; Das BR; Mandava S
    Cancer Detect Prev; 2008; 32(2):168-77. PubMed ID: 18639991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004.
    Rasche M; von Neuhoff C; Dworzak M; Bourquin JP; Bradtke J; Göhring G; Escherich G; Fleischhack G; Graf N; Gruhn B; Haas OA; Klingebiel T; Kremens B; Lehrnbecher T; von Stackelberg A; Tchinda J; Zemanova Z; Thiede C; von Neuhoff N; Zimmermann M; Creutzig U; Reinhardt D
    Leukemia; 2017 Dec; 31(12):2807-2814. PubMed ID: 28443606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
    Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
    Grimwade D; Walker H; Oliver F; Wheatley K; Harrison C; Harrison G; Rees J; Hann I; Stevens R; Burnett A; Goldstone A
    Blood; 1998 Oct; 92(7):2322-33. PubMed ID: 9746770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.